Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Gains from Investment Securities (2016 - 2026)

Pediatrix Medical (MD) has disclosed Gains from Investment Securities for 16 consecutive years, with -$4.2 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 117.9% to -$4.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.9 million through Dec 2025, down 51.55% year-over-year, with the annual reading at $1.4 million for FY2025, 1.17% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$4.2 million at Pediatrix Medical, down from $1.0 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $50.0 million in Q1 2022, with the low at -$5.9 million in Q1 2024.
  • Average Gains from Investment Securities over 5 years is $8.1 million, with a median of $1.3 million recorded in 2023.
  • The sharpest move saw Gains from Investment Securities surged 14757.14% in 2021, then tumbled 519.75% in 2024.
  • Over 5 years, Gains from Investment Securities stood at $47.4 million in 2021, then crashed by 104.42% to -$2.1 million in 2022, then surged by 174.39% to $1.6 million in 2023, then soared by 1421.41% to $23.7 million in 2024, then plummeted by 117.9% to -$4.2 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at -$4.2 million, $1.0 million, and $600000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.